Related Articles
PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein
RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells
A novel danshensu/tetramethypyrazine derivative attenuates oxidative stress‑induced autophagy injury via the AMPK‑mTOR‑Ulk1 signaling pathway in cardiomyocytes
p53 reactivating small molecule PRIMA‑1<sup>MET</sup>/APR‑246 regulates genomic instability in MDA‑MB‑231 cells
Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells